Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search: "Benefits"
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
author_facet:"Canadian Agency for Drugs and Technologies in Health"
dewey-ones:"330 - Economics"
language:"English"
Showing
61
-
80
of
231
Search:
'"Benefits"'
,
query time: 0.01s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
61
CADTH Canadian Drug Expert Committee recommendation: Nusinersen (Spinraza -- Biogen Canada Inc.) : indication : treatment of 5q spinal muscular atrophy
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
62
Pharmacoeconomic review report: Nitisinone (Orfadin) (Sobi Canada Inc.)
Published 2018
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
63
CADTH Canadian Drug Expert Committee recommendation: Darunavir/Cobicistat/Emtricitabine/Tenofovir alafenamide (Symtuza -- Janssen Inc.) : indication: treatment of HIV type 1 (HIV-1...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
64
Pharmacoeconomic review report: Daclizumab (Zinbryta)
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
65
Drugs for pulmonary arterial hypertension : comparative efficacy, safety, and cost-effectiveness
by
Tran, Khai
Published 2015
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
66
Drugs for pulmonary arterial hypertension : comparative efficacy, safety, and cost-effectiveness : recommendations report
Published 2015
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
67
Drugs for pulmonary arterial hypertension : project protocol
Published 2014
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
68
Optimal warfarin management for the prevention of thromboembolic events in patients with atrial fibrillation : review of Canadian economic studies
Published 2011
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
69
Trauma-informed care for adults involved in the correctional system : a review of the clinical effectiveness, cost-effectiveness, and guidelines
by
Williams, D.
,
Frey, Nina
Published 2018
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
70
Nociception monitoring for general anesthesia : a review of clinical effectiveness, cost-effectiveness, and guidelines
by
Banerjee, Srabani
,
MacDougall, Danielle
Published 2018
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
71
CADTH Canadian Drug Expert Committee recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication : adult patients with active psoriatic arthritis (PsA) who have respon...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
72
Pharmacoeconomic review report: Ixekizumab (Taltz) (Eli Lilly Canada Inc.) : indication : treatment of adult patients with active psoriatic arthritis who have responded inadequatel...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
73
Tiered care for chronic non-malignant pain : a review of clinical effectiveness, cost-effectiveness, and guidelines
by
Palylyk-Colwell, Eugenia
,
Wright, Mary-Doug
Published 2019
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
74
Pharmacoeconomic review report: Preservative-free latanoprost 50 [mu]g/mL ophthalmic solution (Monoprost) (Laboratoires Théa)
Published 2018
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
75
Drugs for pulmonary arterial hypertension : comparative efficacy, safety, and cost-effectiveness
by
Tran, Khai
Published 2015
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
76
Pharmacoeconomic review report: Daclizumab (Zinbryta)
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
77
CADTH Canadian Drug Expert Committee recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication : adult patients with active psoriatic arthritis (PsA) who have respon...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
78
Pharmacoeconomic review report: Glucagon nasal powder (Baqsimi) (Eli Lilly Canada Inc.) : indication: for the treatment of severe hypoglycemic reactions which may occur in the mana...
Published 2020
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
79
Pharmacoeconomic review report: Ixekizumab (Taltz) (Eli Lilly Canada Inc.) : indication : treatment of adult patients with active psoriatic arthritis who have responded inadequatel...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
80
Pharmacoeconomic review report: Preservative-free latanoprost 50 [mu]g/mL ophthalmic solution (Monoprost) (Laboratoires Théa)
Published 2018
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
1
2
3
4
5
6
7
8
9
10
11
Back
Narrow Search
Remove Filters
Clear Filter
Author: Canadian Agency for Drugs and Technologies in Health
Clear Filter
Classification: 330 - Economics
Clear Filter
Language: English
Year of Publication
From:
To:
Classification
330 - Economics
610 - Medicine & health
76
140 - Specific philosophical schools
19
700 - The arts; fine & decorative arts
17
580 - Plants (Botany)
3
600 - Technology
2
more ...
615 - Pharmacology & therapeutics
2
100 - Philosophy & psychology
1
363 - Other social problems & services
1
800 - Literature & rhetoric
1
see all ...
less ...
Language
English
Collection
National Center for Biotechnology Information
231
Author
Canadian Agency for Drugs and Technologies in Health
CADTH Canadian Drug Expert Committee
50
Canadian Agency for Drugs and Technologies in Health Rapid Response Service
27
Adcock, Lorna
7
Ho, Chuong
7
Ford, Caitlyn
6
more ...
Grobelna, Aleksandra
5
Argáez, Charlene
4
Chao, Yi-Sheng
4
Gray, Casey
4
McCormack, Suzanne
4
Tran, Khai
4
Banerjee, Srabani
3
Campbell, Kaitryn
3
Loshak, Hannah
3
MacDougall, Danielle
3
Wells, Charlotte
3
Williams, D.
3
Young, Calvin
3
Farrah, Kelly
2
Frey, Nina
2
Jahagirdar, Deepa
2
Kanga, Ismat
2
Poitras, Veronica
2
Visintini, Sarah
2
Adams, Alison
1
Chiu, Stephanie
1
Cowling, Tara
1
De Nanassy, Alina
1
Edge, Rob
1
Harricharan, Sharada
1
Khangura, Sara
1
Klarenbach, Scott
1
Krahn, Murray
1
La Fleur, Philip
1
Lachance, Chantelle
1
Lee, Karen M.
1
Marchand, Dave K.
1
Membe, Stephen K.
1
Narain, Tasha
1
Palylyk-Colwell, Eugenia
1
Picheca, Lory
1
Singh, Sumeet
1
Spry, Carolyn
1
Thompson, Wade
1
Wong, William
1
Wright, Mary-Doug
1
Yeung, Shirley S. T.
1
see all ...
less ...
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?page=4&filter%5B%5D=author_facet%3A%22Canadian+Agency+for+Drugs+and+Technologies+in+Health%22&filter%5B%5D=dewey-ones%3A%22330+-+Economics%22&filter%5B%5D=language%3A%22English%22&lookfor=%22Benefits%22&type=Subject
Send by Email
×
Loading...